The Role of SV40 in Malignant Mesothelioma and Other Human Malignancies

REFERENCES

• Aldieri E., Orecchia S., Ghigo D., Bergandi L., Riganti C., Fubini B., Betta P. G., Bosia A. Simian virus 40 infection down-regulates the expression of nitric oxide synthase in human mesothelial cells. Cancer Res. 2004; 64: 4082–4084, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bocchetta M., Di Resta H., Powers A., Fresco R., Tosolino A., Testa J. R., Pass H. I., Rizzo P., Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl. Acad. Sci. USA 2000; 97: 10214–10219, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bocchetta M., Miele L., Pass H. I., Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2003; 22(1)81–89, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Brinster R. L., Chen H. Y., Messing A., van Dyek T., Levine A. J., Palmiter R. D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. 1984; 37: 367–379, [CSA]
   Google Scholar
• Broaddus C. VII Meeting of the International Mesothelioma Interest Group (I.M.I.G.), BresciaItaly, June, 24–26, 2004
   Google Scholar
• Butel J. S., Lednicky J. A. Cell and molecular biology of simian virus 40: Implications for human infections and disease. JNCI 1999; 91(2)119–134, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Carbone M. Simian virus 40 and human tumors: It is time to study mechanisms. J. Cell. Biochem. 1999; 76(2)189–193, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Carbone M. Institute of Medicine Immunization Safety Review Committee Meeting: Simian Virus-40 Contamination of Polio Vaccine and Cancer, Washington, DC, July, 2002, http://www.iom.edu/event.asp?id= 6696
   Google Scholar
• Carbone M., Rizzo P., Pass H. Simian virus 40: The link with human malignant mesothelioma is well established. Anticancer Res. 2000; 20(2A)875–877, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Cicala C., Pompetti F., Carbone M. SV40 induces mesotheliomas in hamsters. Am. J. Pathol. 1993; 142: 1524–1533, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Coppelli F. M., Grandis J. R. Oligonucleotides as anticancer agents: From the benchside to the clinic and beyond. Curr. Pharm. Des. 2005; 11(22)2825–2840, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Diamandopoulos G. T., McLane M. F. Effect of host age, virus dose, and route of inoculation on tumor incidence, latency, and morphology in Syrian hamsters inoculated intravenously with oncogenic DNA simian virus 40. J. Natl. Cancer Inst. 1975; 55(2)479–482, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Foddis R., De Rienzo A., Broccoli D., Boccheta M., Stekala E., Rizzo P., Tosolini A., Grobelny J. V., Jhanwar S. C., Pass H. I., Testa J. R., Carbone M. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21: 1434–1442, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Garson K., Macdonald E., Dube M., Bao R., Hamilton T. C., Vanderhyden B. C. Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1. J. Soc. Gynecol. Invest. 2003; 10(4)244–250, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gazdar A. F., Butel J. S., Carbone M. SV40 and human tumours: Myth, association or causality. Nat. Rev. Cancer 2002; 2(12)957–964, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Greenberg N. M., DeMayo F., Finegold M. J., Medina D., Tilley W. D., Aspinall J. O., Cunha G. R., Donjacour A. A., Matusik R. J., Rosen J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 1995; 92(8)3439–3443, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985; 15(6015)115–122, 315[CROSSREF], [CSA]
   Google Scholar
• Herndon J. E., Green M. R., Chahinian A. P., Corson J. M., Suzuki Y., Vogelzang N. J. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 1998; 113: 723–731, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hicks S. M., Vassallo J. D., Dieter M. Z., Lewis C. L., Whiteley L. O., Fix A. S., Lehman-McKeeman L. D. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis. Toxicology 2003; 187(2–3)217–228, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Karagiannis T. C., El-Osta A. RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther. 2005; 12(10)787–795, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kasper J. S., Kuwabara H., Arai T., Hamid Ali S., DeCaprio J. A. Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J. Virol. 2005; 79: 11685–11692, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kirschstein R. L., Gerber P. Ependymomas produced after intracerebral inoculation of SV40 into new-born hamsters. Nature 1962; 195: 299–300, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kops S. P. Re: Debate on the link between SV40 and human cancer continues. J. Natl. Cancer Inst. 2002; 94(3)229, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lopez-Rios F., Illei P., Rusch V., Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004; 364: 1157–1166, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• MacLachlan D. S. SV40 in human tumors: New documents shed light on the apparent controversy. Anticancer Res. 2002; 22(6B)3495–3499, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Manfredi J. J., Dong J., Liu W. J., Resnick-Silverman L., Qiao R., Chahinian P., Saric M., Gibbs A. R., Phillips J. I., Murray J., Axten C. W., Nolan R. P., Aaronson S. A. Evidence against a role for SV40 in human mesothelioma. Cancer Res. 2005; 65(7)2602–2609, 1, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• McNees A. L., White Z. S., Zanwar P., Vilchez R. A., Butel J. S. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J. Clin. Virol. 2005; 34: 52–62, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakata Y., Kim T. K., Shetzline S., Gewirtz A. M. Nucleic acid modulation of gene expression: Approaches for nucleic acid therapeutics against cancer. Crit. Rev. Eukaryot. Gene. Express. 2005; 15(2)163–182, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Parkes W. R. Silicates and lung disease in occupational lung disorders, 2nd ed. Butterworths, London 1982; 233–332
   Google Scholar
• Rizzo P., Bocchetta M., Powers A., Foddis R., Stekala E., Pass H. I., Carbone M. SV40 and the pathogenesis of mesothelioma. Semin. Cancer Biol. 2001; 11: 63–71, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Santarelli R., Tzeng Y. J., Zimmermann C., Guhl E., Graessmann A. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals. Oncogene 1996; 12(3)495–505, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Shah K. V. Causality of mesothelioma: SV40 question. Thorac. Surg. Clin. 2004; 14: 497–504, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Stenton S. C. Asbestos, simian virus 40 and malignant mesothelioma. Thorax 1997; 52: S52–S57, [INFOTRIEVE], [CSA]
   Google Scholar
• Immunization safety review: SV40 contamination of polio vaccine and cancer, K. Stratton, D. A. Almario, M. C. McCormick. National Academies Press, Washington, DC 2003, http://www.nap.edu/books/0309086108/html/index.html
   Google Scholar
• Strickler H. D., International SV40 Working Group. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol. Biomarkers Prev. 2001; 10(5)523–532, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Suzuki M., Toyooka S., Shivapurkar N., Shigematsu H., Miyajima K., Takahashi T., Stastny V., Zern A. L., Fujisawa T., Pass H. I., Carbone M., Gazdar A. F. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 2005; 24(7)1302–1308, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sweet B. H., Hilleman M. R. The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med. 1960; 105: 420–427, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Toyooka S., Pass H. I., Shivapurkar N., Fukuyama Y., Maruyama R., Toyooka K., Gilcrease M., Farinas A., Minna J. D., Gazdar A. F. Aberrant methylation and simian virus 40 Tag sequences in malignant mesothelioma. Cancer Res. 2001a; 61: 5727–5730, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Toyooka S., Toyooka K. O., Maruyama R., Virmani A. K., Girard L., Miyajima K., Harada K., Ariyoshi Y., Takahashi T., Sugio K., Brambilla E., Gilcrease M., Minna J. D., Gazdar A. F. DNA methylation profiles of lung tumors. Mol. Cancer Ther. 2001b; 1(1)61–67, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Vilchez R. A., Butel J. S. Emergent human pathogen simian virus 40 and its role in cancer. Clin. Microbiol. Rev. 2004; 17(3)495–508, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vilchez R. A., Kozinetz C. A., Arrington A. S., Madden C. R., Butel J. S. Simian virus 40 in human cancers. Am. J. Med. 2003; 114: 675–684, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vultur A., Arulanandam R., Turkson J., Niu G., Jove R., Raptis L. Stat3 is required for full neoplastic transformation by the simian virus 40 large tumor antigen. Mol. Biol. Cell 2005; 16: 3832–3846, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Waheed I., Sheng Guo Z., Chen G. A., Weiser T. S., Nguyen D. M., Schrump D. S. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells. Cancer Res. 1999; 59: 6068–6073, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Weggen S., Bayer T. A., von Deimling A., Reifenberger G., von Schweinitz D., Wiestler O. D., Pietsch T. Low frequency of SV40., JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol. 2000; 10(1)85–92, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wikenheiser K. A., Clark J. C., Linnoila R. I., Stahlman M. T., Whitsett J. A. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res. 1992; 52(19)5342–5352, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Xie Y. C., Hwang C., Overwijk W., Zeng Z., Eng M. H., Mule J. J., Imperiale M. J., Restifo N. P., Sanda M. G. Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J. Natl. Cancer Inst. 1999; 91(2)169–175, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar